About LFB
LFB is a pharmaceutical company, the first French company in the biotech field, the fifth largest pharmaceutical company in plasma-derived medicinal products, and the third laboratory supplying drugs to hospitals in France. LFB commercializes a wide range of 19 plasma-derived medicinal products addressing more than 80 pathologies in three therapeutic fields: Immunology, Homeostasis, and Intensive Care. Each year in France, 500,000 patients are treated with LFB's products for chronic pathologies or for emergency cases. In the biotechnology field, LFB develops monoclonal antibodies and a line of therapeutic proteins through transgenic technology with GTC Therapeutics.
- Focus : Manufacturer
- Industry : Pharma
Product portfolio of LFB
News about LFB
Here you will find LFB SA
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
